
2.44 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 1.43 Today|||52-Week Range 4.68 | +26.42% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $135.8M |
Trevi Therapeutics, Inc. 195 Church Street New Haven Connecticut 06510 |
Jennifer L. Good | President, Chief Executive Officer & Director |
Lisa Delfini | Chief Financial Officer |
Thomas R. Sciascia | Chief Science Officer |
Danine Summers | Vice President-Medical Affairs |
David J. Clark | Chief Medical Officer |